Product Image

Natural Vitamin K2 MK-7 with MenaQ7 100 mcg

Doctor's Best
4.8
★ ★ ★ ★ ★
(19789 ratings)
Vitamin K 100 mcg
Product Image
Score86
A strong focused K2 choice with branded MK-7, a useful amount, and good value; take the dry capsule with dietary fat.
How scoring works
Quantity:60 Veggie Cap(s) • (60 servings)
Goals:
General Health
Heart Health
Anti-Aging
Cardiovascular Support
Bone Health

Score 86

A strong focused K2 choice with branded MK-7, a useful amount, and good value; take the dry capsule with dietary fat.
How scoring works
$13.99($0.23 per serving)
Vitacost
$ 15.39
Vitacost
$ 15.39
iHerb
$ 13.99
Pure Formulas
$ 23.37
Report prices

Analysis

Branded MenaQ7 supplies the long-lasting MK-7 form at a practical daily amount. It supports vitamin K-dependent proteins involved in directing calcium toward bone and away from soft tissue.

The one-ingredient design and clear subtype disclosure make the product easy to combine with a separately tailored vitamin D or mineral routine. A dry capsule lacks a lipid carrier, so taking it with food containing fat is sensible.

The product fits adults seeking focused, high-value K2 without bundled nutrients. It provides depth in calcium regulation but does not cover broader bone or cardiovascular pathways.

Who is it for
  • Adults seeking full-dose daily MK-7
  • Users who value branded source identity
  • People building a customized bone-support stack
Best for
  • Vitamin K-dependent calcium handling
  • Bone-protein activation
  • Focused arterial-support nutrition

Pros

  • Branded MenaQ7 source
  • Well-aligned daily amount
  • Strong practical value

Cons

  • Dry capsule lacks a lipid carrier
  • No vitamin D companion
  • Narrow single-pathway support

Warnings

  • MK-7 can oppose warfarin and related vitamin K antagonist medicines
  • Do not change vitamin K intake without the prescriber managing anticoagulation
  • Take with a fat-containing meal unless the label directs otherwise

Nutrient quality

94 Highest impact

Menaquinone-7 is a well-regarded, long-acting vitamin K2 form, and the vitamin K2 amount is meaningful for routine standalone support. The amount is not unnecessarily aggressive for a focused vitamin K2 supplement, while the single-active formula is not padded with low-value ingredients.

Ingredient transparency

84 Highest impact

Specific amounts are listed for every supplied active ingredient. No proprietary blend hides active doses, while capsule, softgel, or tablet excipients are not included in the supplied details.

Customer satisfaction

73 High impact

The supplied aggregate satisfaction metric is very strong, and the large amount of aggregate feedback makes the metric highly stable. No review excerpts were provided, so recurring complaints and purpose-specific experiences cannot be checked.

Value for money

93 Highest impact

A focused formula and well-regarded vitamin K2 form support good value. Each serving provides a meaningful active amount with little burden, while the formula avoids unnecessary active extras.

Report analysis

Goals

General Health
Impact
Highest effect
A- Goal FitA+ Strength of SupportC+ CoverageA Formula Quality
Vitamin K · 100 mcg

Branded MK-7 supplies a clearly disclosed and well-targeted form of vitamin K2 for calcium handling, bone support, and normal vascular function. The focused formula uses a long-lasting K2 form with strong source transparency.

A dry capsule without stated fat-intake guidance may not optimize absorption, and the formula does not include complementary vitamin D. Vitamin K2 can interfere with warfarin and related vitamin K antagonists, so people using those medicines need clinician-managed, consistent vitamin K intake.

Study evidence
Vitamin K Supportive 34 studies
Heart Health
Impact
Highest effect
A- Goal FitA+ Strength of SupportC CoverageA+ Formula Quality
Vitamin K · 100 mcg

Vitamin K2 as branded MenaQ7 MK-7 directly supports calcium handling relevant to arterial flexibility. The 100 mcg amount is meaningful and the subtype is fully disclosed.

The focused capsule provides excellent depth for one arterial-health pathway but does not cover lipids, vascular tone, or cardiac energy. MK-7 directly opposes warfarin and related vitamin K antagonists, so intake should remain medically managed and consistent for users of those medicines.

Study evidence
Vitamin K Mixed 62 studies
Anti-Aging
Impact
Highest effect
B Goal FitA+ Strength of SupportC CoverageA+ Formula Quality
Vitamin K · 100 mcg

Vitamin K2 as MK-7 supports healthy calcium placement in arteries and bones, making it relevant to vascular and skeletal aging. Human evidence is promising for these age-related markers but does not establish broad healthspan extension by itself.

The 100 mcg amount is substantial and clearly disclosed. Branded MenaQ7 provides excellent source identification, though the dry capsule has no stated lipid carrier. People taking warfarin or other vitamin K antagonist medicines should keep vitamin K intake consistent and follow their prescriber’s guidance.

Study evidence
Vitamin K Supportive 27 studies
Cardiovascular Support
Impact
Highest effect
B Goal FitA+ Strength of SupportD+ CoverageA+ Formula Quality
Vitamin K · 100 mcg

MK-7 vitamin K2 activates proteins involved in calcium handling and may support arterial health. Evidence for this mechanism is credible, though direct cardiovascular outcome evidence is less established than the nutrient’s biological role.

Branded MenaQ7 and a clearly stated amount provide strong quality and depth in one pathway. MK-7 can interfere with warfarin and related vitamin K antagonists, so users of those medicines need clinician-guided consistency before changing intake.

Study evidence
Vitamin K Supportive 40 studies
Bone Health
Impact
Highest effect
A- Goal FitA+ Strength of SupportC- CoverageB Formula Quality
Vitamin K · 100 mcg

Branded MenaQ7 supplies a clearly disclosed MK-7 amount that is well aligned with vitamin K-dependent bone protein activity. The form and dose make it a strong targeted cofactor for mineral placement.

Its narrow design does not provide calcium, magnesium, vitamin D, or protein-matrix nutrients, so it is not complete bone support by itself. MK-7 can counteract warfarin and related vitamin K antagonists, requiring consistent intake coordinated with the prescribing clinician.

Study evidence
Vitamin K Supportive 78 studies

Ingredients

IngredientAmount per serving
Vitamin K2 (MenaQ7 Menaquinone)
100 mcg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
B+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

Branded MenaQ7 supplies a well-aligned MK-7 dose with strong source disclosure. The inexpensive serving supports good value, though the dry capsule lacks stated fat-intake guidance. MK-7 can interfere with warfarin and related vitamin K antagonists, so people taking those medicines should use it only with managed, consistent vitamin K intake.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  3. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  4. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  5. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  6. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  7. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  8. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  9. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  10. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  11. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  12. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  13. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  14. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  15. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  16. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  17. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  18. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  19. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  20. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  21. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K